Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.44 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22085186 | 0.87 | LTA4H (0.51) | LTA4HMAPTS1PR1S1PR3SPHK1 | |
| SCHEMBL4242289 | 0.87 | LTA4H (0.61) | LTA4HMAPTRAB9AS1PR1S1PR3 | |
| SCHEMBL6286723 | 0.86 | LTA4H (0.47) | LTA4HS1PR1S1PR3SPHK1SPHK2 | |
| SCHEMBL11038424 | 0.84 | LTA4H (0.49) | LTA4HS1PR1S1PR3SPHK1SPHK2 | |
| SCHEMBL19234507 | 0.83 | SPHK1 (0.53) | LTA4HRAB9AS1PR1S1PR3SPHK1 | |
| SCHEMBL10884809 | 0.82 | S1PR1 (0.54) | LTA4HRAB9AS1PR1S1PR3KMT2A | |
| SCHEMBL24324831 | 0.81 | SPHK1 (0.61) | S1PR1S1PR3SPHK1SPHK2S1PR2 | |
| SCHEMBL20715888 | 0.81 | GAA (0.56) | LTA4HMAPTS1PR1S1PR3SPHK1 | |
| SCHEMBL20238865 | 0.81 | LTA4H (0.67) | LTA4HS1PR1S1PR3SPHK1SPHK2 | |
| SCHEMBL7132441 | 0.81 | LTA4H (0.55) | LTA4HS1PR1S1PR3SPHK1SPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140315973-A1 | PARP-1 INHIBITORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-23 | — | — | US | disclosed |
| WO-2013052006-A1 | PARP-1 INHIBITORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2013-04-11 | — | — | WO | disclosed |
| US-7481781-B2 | Ultrasound therapy | GENDEL LIMITED (GB) | 2009-01-27 | — | — | US | disclosed |
| EP-1506039-B1 | ABLATION DEVICE | GENDEL LTD (GB) | 2008-10-29 | — | — | EP | disclosed |
| WO-2006044716-A2 | CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ('PNAs') WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER | WASHINGTON UNIVERSITY IN ST.LOUIS (US) | 2006-04-27 | — | — | WO | disclosed |
| EP-1196143-B1 | USE OF AN ELECTRIC FIELD FOR SENSITISING RED BLOOD CELLS TO ULTRASOUND | UUTECH LTD (GB) | 2006-03-01 | — | — | EP | disclosed |
| US-20050043726-A1 | Device II | GENDEL LIMITED (GB) | 2005-02-24 | — | — | US | disclosed |
| US-6821274-B2 | DISRUPTING DISEASED AREA WHILE MINIMIZING HARM TO NEIGHBORING HEALTHY CELLS; PRETREATMENT WITH ELECTRIC FIELD | GENDEL LTD. (IE) | 2004-11-23 | — | — | US | disclosed |
| US-6812204-B1 | ELECTROSENSITIZING RED BLOOD CELL; APPLYING SOUND WAVES | GENDEL LIMITED (GB) | 2004-11-02 | — | — | US | disclosed |
| WO-2004083391-A2 | TARGETED AND REGIONAL CELLULAR ABLATION IN ZEBRAFISH | WASHINGTON UNIVERSITY IN ST. LOUIS (US) | 2004-09-30 | — | — | WO | disclosed |
| EP-1253912-A1 | APPARATUS FOR PROVIDING A RED BLOOD CELL CARRIER | Gendel Limited (GB) | 2002-11-06 | — | — | EP | disclosed |
| US-20020151004-A1 | Delivery vehicles and methods for using the same | CRAIG ROGER (GB) | 2002-10-17 | — | — | US | disclosed |
| WO-2002007752-A2 | RED BLOOD CELL AS VEHICLE FOR AGENT-MEMBRANE TRANSLOCATION SEQUENCE CONJUGATE | GENDEL LIMITED (GB) | 2002-01-31 | — | — | WO | disclosed |
| US-20020009706-A1 | Method for loading cells with an agent | MCHALE ANTHONY P (IE) | 2002-01-24 | — | — | US | disclosed |
| US-20010053549-A1 | Loading method | GENDEL LIMITED (GB) | 2001-12-20 | — | — | US | disclosed |
| US-20010031499-A1 | Loading system and method for using the same | GENDEL LIMITED (GB) | 2001-10-18 | — | — | US | disclosed |
| WO-2001058432-A1 | APPARATUS FOR PROVIDING A RED BLOOD CELL CARRIER | GENDEL LIMITED (GB) | 2001-08-16 | — | — | WO | disclosed |
| US-20010008758-A1 | Delivery of an agent | UUTECH LIMITED (GB) | 2001-07-19 | — | — | US | disclosed |
| EP-0970232-A2 | NON-IMMUNOGENIC PRODRUGS AND SELECTABLE MARKERS FOR USE IN GENE THERAPY | Chiron Corporation (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998030709-A2 | NON-IMMUNOGENIC PRODRUGS AND SELECTABLE MARKERS FOR USE IN GENE THERAPY | CHIRON CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |